The efficacy of Homeopathic medicines in the prevention of COVID-19 in Quarantined or Exposed Individuals

Double blind, placebo controlled, multi-centric, cluster randomized study to evaluate the efficacy of Homeopathic medicines in the prevention of COVID-19 in Quarantined or Exposed Individuals

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/05/025491

Enrollment

1000

Registered

2020-05-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Homeopathy medicine: 1. Arsenic Album 30c potency 2. Bryonia alba 30c potency 3. Camphora 1M potency 4. Coronavirus related nosodes (30c potency) 5. Matching Placebo pills Intervention2

Eligibility

Inclusion criteria

Inclusion criteria: Quarantined individuals Covid19 exposure risk groups (For example, police, hospital staff, etc.) The participant is willing and able to give informed consent for participation in the study Agrees not to self-medicate with potential antivirals

Exclusion criteria

Exclusion criteria: i. Subjects who are detected SARS-CoV-2 positive at baseline ii. Inability to be followed up for the trial period iii. Subjects who are scheduled to receive any other investigational drug during the study.

Design outcomes

Primary

Measure	Time frame
a. Number of people turning symptomatic Number of people turning Covid19 positive c. Number of people recovering after turning positive d. Number of deaths, if any, if get infectionTimepoint: Baseline, week 2 and week 4	—

Secondary

Measure	Time frame
a. The duration of the period of illness for those get infected b. The severity of the illness of those who get infected.Timepoint: Day 0 and Day 30	—

Countries

India

Contacts

Public ContactDr Rajesh Shah

Life Force Foundation Trust

sanjivak@gmail.com02266888888

Outcome results